These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6387924

  • 1. Exogenous surfactant therapy in hyaline membrane disease.
    Gitlin JD, Parad R, Taeusch HW.
    Semin Perinatol; 1984 Oct; 8(4):272-82. PubMed ID: 6387924
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.
    Vidyasagar D, Maeta H, Raju TN, John E, Bhat R, Go M, Dahiya U, Roberson Y, Yamin A, Narula A.
    Pediatrics; 1985 Jun; 75(6):1132-42. PubMed ID: 3846883
    [Abstract] [Full Text] [Related]

  • 11. Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
    Rossello JD, Hayward PE, Martell M, Del Barco M, Margotto P, Grandzoto J, Bastida J, Peña J, Villanueva D.
    J Perinat Med; 1997 Jun; 25(3):280-7. PubMed ID: 9288665
    [Abstract] [Full Text] [Related]

  • 12. Pulmonary surfactant replacement in respiratory distress syndrome.
    Vidyasagar D, Shimada S.
    Clin Perinatol; 1987 Dec; 14(4):991-1015. PubMed ID: 3322633
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH, Piña-Ceballos VM, Beyer-Obezo J, Gutiérrez-Martín A, Martínez-Hinojosa B, Flores-Támez ME.
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Study of treatment of hyaline membrane disease with pulmonary surfactant replacement in premature infant].
    Ji SP, Zhang XL, Ma WX, Sun YP, Li XH, Yu JH.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Apr; 19(4):248. PubMed ID: 17448287
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of severe hyaline membrane disease with a single-dose of natural exogenous surfactant of porcine origin. A randomized trial: immediate effects and outcome at 28 days of life].
    Walti H, Relier JP, Huon C, Monset-Couchard M, Scemama M, De Gamarra E, Moriette G, Curstedt T, Robertson B.
    Arch Fr Pediatr; 1990 May; 47(5):329-34. PubMed ID: 2196030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.